Cdk9-in-7 is a highly selective, orally active CDK9/cyclin T inhibitor. CDK9-IN-7 induces apoptosis in non-small cell lung cancer (NSCLC) cells, blocks the cell cycle in the G2 phase, and has inhibitory NSCLC stem cell properties.
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: ICA14160-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review